CTRI/2022/04/041997招募中未知
In vitro susceptibility of Ceftriaxone or Ceftriaxone combination with Sulbactam & Tazobactam in community acquired and nosocomial infections against gram-negative and gram -positive bacteria
试验速览
- 阶段
- 未知
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •180 Non-repetitive clinical samples such as blood, urine, respiratory samples, tissue, pus, cerebrospinal fluid (CSF), ascetic fluid etc.
排除标准
- •Clinical isolates from repeat cultures performed during in-patient follow-up that were previously recruited into the study
研究者
相似试验
已完成
2 期
The effect of cefotaxime on improvement of pediatric dysenteryDysentery.Gastroenteritis and colitis of unspecified originIRCT2016102211145N18Vice Chancellor of Research and Technology, Kashan University of Medical Sciences100
尚未招募
不适用
Study comparing antibiotics versus placebo at time of catheter removal post robotic prostate removalurinary tract infectionprostate cancerACTRN12619000768190A/Prof John Yaxley800
已完成
不适用
The efficacy and safety evaluation of ceftriaxone and sulbactam combination (1.5 gram) in patients with skin and soft tissue infections: an open label, parallel, randomized, prospective comparative trialSkin and soft tissue infectionsInfections and InfestationsISRCTN76443564Ranbaxy Laboratories Ltd (India)400
进行中（未招募）
不适用
Efficacy assessment of ceftriaxone therapy in patients with amyotrophic lateral sclerosis. - NDAmyotrophic lateral sclerosis (ALS)MedDRA version: 6.1Level: PTClassification code 10002026EUCTR2007-004165-17-ITAZIENDA OSPEDALIERA PISANA
已完成
3 期
The comparison of ciprofloxacin and ceftriaxone on improvement of dysenteryDysentery.Gastroenteritis and colitis of unspecified originIRCT2015061117985N2Vice chancellor for research, Kashan University of Medical Sciences60